Aggressive NK Cell Leukemia - 125 Studies Found
Recruiting |
: A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies :
|
Completed |
: Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma :
: |
Active, not recruiting |
: Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers :
|
Completed |
: Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant :
: |
Completed |
: Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma :
: |
Completed |
: Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies :
|
Terminated |
: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia :
|
Active, not recruiting |
: Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer :
: |
Recruiting |
: Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer :
: Other: cytology specimen collection procedure Correlative studies |
Completed |
: Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery :
: |